Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BDTX-1535 |
Synonyms | |
Therapy Description |
BDTX-1535 is an irreversible fourth-generation EGFR inhibitor with activity against EGFR mutations, including mutations associated with resistance to third-generation inhibitors, which potentially reduces tumor growth (Eur J Cancer Vol 174, Supp 1:S14; Eur J Cancer, Vol 174, Supp 1:S22). |